Last updated: 8 December 2022 at 5:30pm EST

Dr. Giulia C. Kennedy Ph.D. Net Worth




The estimated Net Worth of Giulia C Kennedy is at least $11.3 Milion dollars as of 6 December 2022. Dr Kennedy owns over 1,023 units of Veracyte Inc stock worth over $2,000,210 and over the last 6 years he sold VCYT stock worth over $8,562,055. In addition, he makes $703,000 as Global Chief Scientific Officer & Chief Medical Officer at Veracyte Inc.

Dr D VCYT stock SEC Form 4 insiders trading

Dr has made over 24 trades of the Veracyte Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,023 units of VCYT stock worth $27,652 on 6 December 2022.

The largest trade he's ever made was selling 52,015 units of Veracyte Inc stock on 4 March 2021 worth over $2,567,460. On average, Dr trades about 9,484 units every 34 days since 2019. As of 6 December 2022 he still owns at least 65,970 units of Veracyte Inc stock.

You can see the complete history of Dr Kennedy stock trades at the bottom of the page.





Dr. Giulia C. Kennedy Ph.D. biography

Dr. Giulia C. Kennedy Ph.D. is the Global Chief Scientific Officer & Chief Medical Officer at Veracyte Inc.

What is the salary of Dr D?

As the Global Chief Scientific Officer & Chief Medical Officer of Veracyte Inc, the total compensation of Dr D at Veracyte Inc is $703,000. There are 1 executives at Veracyte Inc getting paid more, with Bonnie H. Anderson having the highest compensation of $1,252,000.



How old is Dr D?

Dr D is 62, he's been the Global Chief Scientific Officer & Chief Medical Officer of Veracyte Inc since . There are 2 older and 7 younger executives at Veracyte Inc. The oldest executive at Veracyte Inc is Dr. Tina S. Nova Ph.D., 67, who is the Pres of CLIA U.S. Bus..

What's Dr D's mailing address?

Giulia's mailing address filed with the SEC is 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Veracyte Inc

Over the last 11 years, insiders at Veracyte Inc have traded over $201,983,044 worth of Veracyte Inc stock and bought 75,122 units worth $1,149,322 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Nicole Vitullo oraz Jesse I Treu. On average, Veracyte Inc executives and independent directors trade stock every 20 days with the average trade being worth of $804,905. The most recent stock trade was executed by John Leite on 4 September 2024, trading 5,479 units of VCYT stock currently worth $163,165.



What does Veracyte Inc do?

veracyte is a pioneering genomic diagnostics company. our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. we ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. we are giving patients a clearer path forward. through scientific rigor we employ the best tools, best science and best minds to create tests that enable a more accurate diagnosis without the need for risky, costly and often unnecessary surgery. veracyte consistently brings to bear evidence that is unprecedented in genomic tests, thereby changing today's clinical practice standards. we are making a difference in the lives of physicians and patients. we are doing something real. .



What does Veracyte Inc's logo look like?

Veracyte Inc logo

Complete history of Dr Kennedy stock trades at Veracyte Inc

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
6 Dec 2022 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 1,023 $27.03 $27,652
6 Dec 2022
65,970
11 Nov 2022 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 2 $14.34 $29
11 Nov 2022
68,003
4 Nov 2022 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 1,023 $25.00 $25,575
4 Nov 2022
68,001
5 Aug 2022 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 1,028 $26.54 $27,283
5 Aug 2022
70,032
3 Mar 2022 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 23,003 $25.12 $577,835
3 Mar 2022
61,391
6 Dec 2021 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 15,357 $37.71 $579,112
6 Dec 2021
47,912
7 Sep 2021 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 13,457 $50.55 $680,251
7 Sep 2021
50,049
23 Jun 2021 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 4,375 $24.69 $108,019
23 Jun 2021
56,262
4 Jun 2021 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 9,081 $34.63 $314,475
4 Jun 2021
51,887
4 Mar 2021 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 52,015 $49.36 $2,567,460
4 Mar 2021
53,724
2 Dec 2020 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 14,015 $56.88 $797,173
2 Dec 2020
78,312
6 Oct 2020 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 2,500 $20.21 $50,525
6 Oct 2020
81,899
4 Sep 2020 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 7,027 $31.10 $218,540
4 Sep 2020
79,399
31 Jul 2020 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 20,000 $20.21 $404,200
31 Jul 2020
100,487
13 Jul 2020 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 16,738 $13.05 $218,431
13 Jul 2020
97,225
2 Jun 2020 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 10,786 $26.22 $282,809
2 Jun 2020
80,487
3 Mar 2020 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 32,881 $25.39 $834,849
3 Mar 2020
81,274
5 Dec 2019 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 32,803 $14.34 $470,395
5 Dec 2019
79,665
2 Dec 2019 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 15,327 $26.47 $405,706
2 Dec 2019
46,862
27 Nov 2019 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 3,697 $14.34 $53,015
27 Nov 2019
51,146
3 Sep 2019 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 15,327 $25.32 $388,080
3 Sep 2019
47,449
12 Aug 2019 Giulia C Kennedy
Chief Scientific i Med Officer
Sprzedaż 32,897 $25.39 $835,255
12 Aug 2019
48,037
4 Mar 2019 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 17,625 $5.98 $105,398
4 Mar 2019
66,249
28 Feb 2019 Giulia C Kennedy
Chief Scientific i Med Officer
Opcja Ćwiczenie 37,375 $7.99 $298,626
28 Feb 2019
86,775


Veracyte Inc executives and stock owners

Veracyte Inc executives and other stock owners filed with the SEC include: